JP2015198638A - Bifidobacteria fermentation method and proliferation method - Google Patents
Bifidobacteria fermentation method and proliferation method Download PDFInfo
- Publication number
- JP2015198638A JP2015198638A JP2014158382A JP2014158382A JP2015198638A JP 2015198638 A JP2015198638 A JP 2015198638A JP 2014158382 A JP2014158382 A JP 2014158382A JP 2014158382 A JP2014158382 A JP 2014158382A JP 2015198638 A JP2015198638 A JP 2015198638A
- Authority
- JP
- Japan
- Prior art keywords
- bifidobacteria
- pumpkin
- mass
- composition
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000186000 Bifidobacterium Species 0.000 title claims abstract description 130
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000000855 fermentation Methods 0.000 title abstract description 44
- 230000004151 fermentation Effects 0.000 title abstract description 44
- 230000035755 proliferation Effects 0.000 title abstract 4
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 135
- 235000000832 Ayote Nutrition 0.000 claims abstract description 131
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 131
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 130
- 239000000203 mixture Substances 0.000 claims abstract description 62
- 239000000463 material Substances 0.000 claims abstract description 51
- 240000001980 Cucurbita pepo Species 0.000 claims abstract description 40
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 31
- 230000000968 intestinal effect Effects 0.000 claims description 16
- 239000007952 growth promoter Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 abstract description 30
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 240000004244 Cucurbita moschata Species 0.000 description 91
- 239000000047 product Substances 0.000 description 48
- 239000000843 powder Substances 0.000 description 16
- 239000007858 starting material Substances 0.000 description 14
- 241000186012 Bifidobacterium breve Species 0.000 description 11
- 241001608472 Bifidobacterium longum Species 0.000 description 11
- 229940009291 bifidobacterium longum Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 241000219122 Cucurbita Species 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 229940004120 bifidobacterium infantis Drugs 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 235000009200 high fat diet Nutrition 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000009852 Cucurbita pepo Nutrition 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 3
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- -1 lactose Sugar alcohols Chemical class 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241001134770 Bifidobacterium animalis Species 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 201000006082 Chickenpox Diseases 0.000 description 2
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033546 Pallor Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 235000010358 acesulfame potassium Nutrition 0.000 description 2
- 229960004998 acesulfame potassium Drugs 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940118852 bifidobacterium animalis Drugs 0.000 description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000502561 Acacia irrorata Species 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000021446 Apple puree Nutrition 0.000 description 1
- 241001655328 Bifidobacteriales Species 0.000 description 1
- 241000741973 Bifidobacterium breve DSM 20213 = JCM 1192 Species 0.000 description 1
- 241000186148 Bifidobacterium pseudolongum Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000061464 Cucurbita mixta Species 0.000 description 1
- 235000003949 Cucurbita mixta Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001228709 Suruga Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000020299 breve Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000013572 fruit purees Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 238000013224 high-fat diet-induced obese mouse Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000021579 juice concentrates Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229960000816 magnesium hydroxide Drugs 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229960000869 magnesium oxide Drugs 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、ビフィズス菌の増殖を促進すると共に、ビフィズス菌の生残菌数を向上させるビフィズス菌醗酵方法またはビフィズス菌増殖方法に関する。より詳細には、ビフィズス菌のカボチャ破砕物またはカボチャ搾汁を使用した醗酵方法及び腸内細菌におけるビフィズス菌の増殖方法に関する。 The present invention relates to a bifidobacteria fermentation method or a bifidobacteria growth method that promotes the growth of bifidobacteria and increases the number of surviving bacteria of the bifidobacteria. More specifically, the present invention relates to a fermentation method using a pumpkin crushed or pumpkin juice of bifidobacteria and a method of growing bifidobacteria in enteric bacteria.
食に対する意識が向上し、日常の食生活を通して健康を増進したり疾病を予防したりすることに対し、関心を持つ消費者が増加している状況下において、「腸内フローラバランスを改善することにより動物に有益な効果をもたらす生菌添加物」であるプロバイオティクスについては、各種栄養素の摂取強化とは異なる観点で健康増進等を維持向上させる手段として注目されている。プロバイオティクスの条件としては、「安全であり、腸内細菌叢を構成する微生物であり、胃液などの消化液に対して生存耐性を有し、腸管に定着し易く、有用な性質を有する、一定以上の生菌数を一度に摂取できる」ことなどが挙げられ、中でも、一定以上の数の生きた微生物を経口摂取することがプロバイオティクスを有効に活用するための重要な要因の一つとなっている。このプロバイオティクスにおいて代表的な微生物としては、Lactobacillus属細菌、Enterococcus属細菌やBifidobacterium属細菌(以下、「ビフィズス菌」という。)が知られている。 In a situation where consumers are interested in increasing awareness of food and improving health and preventing illness through daily eating habits, “improving intestinal flora balance. Probiotics, which are “live bacteria additives that have beneficial effects on animals”, are attracting attention as a means for maintaining and improving health and the like from a viewpoint different from the enhancement of intake of various nutrients. The probiotic conditions are: “It is a microorganism that is safe and constitutes the intestinal flora, has survival resistance to digestive juices such as gastric juice, is easy to settle in the intestinal tract, and has useful properties. One of the important factors for effective use of probiotics is that oral intake of a certain number or more of living microorganisms is one of the important factors. It has become. Lactobacillus genus bacteria, Enterococcus genus bacteria and Bifidobacterium genus bacteria (hereinafter referred to as “Bifidobacterium”) are known as representative microorganisms in this probiotic.
ビフィズス菌は、生誕時の腸内において優勢な細菌であるが、その後徐々にLactobacillus属細菌や生体に悪影響を及ぼす可能性がある細菌に置換され腸内細菌におけるビフィズス菌の占める割合が徐々に低下して行くことが知られている。このことに着目し、ビフィズス菌をプロバイオティクスとして活用する試みがなされている。一方、ビフィズス菌は、偏性嫌気性菌であるため生育において酸素の影響を受け、また、増殖を促進させる因子を添加しなければ特に乳系培地で十分な増殖ができなかったり、増殖しても生菌率が高くないなどの課題を有しており、生きた状態のビフィズス菌を密度高く含有する経口組成物を工業的に如何に安価で製造するかが大きな課題点となっていた。 Bifidobacteria are the dominant bacteria in the intestine at birth, but then gradually replaced with Lactobacillus bacteria or bacteria that may adversely affect the living body, the proportion of bifidobacteria in intestinal bacteria gradually decreases It is known to go. Paying attention to this, attempts have been made to utilize bifidobacteria as probiotics. On the other hand, bifidobacteria are obligately anaerobic bacteria, so they are affected by oxygen during growth. However, there is a problem that the viable bacteria rate is not high, and it has been a big problem how to manufacture an oral composition containing a high density of bifidobacteria in a living state at low cost industrially.
そこで生菌数の多い経口組成物を得る技術がいくつか提案されている。例えば、ラクトコッカス・ラクティスと混合して培養する技術(特許文献1)さつまいもと焼酎粕を用いてビフィズス菌の増殖を促進する技術(特許文献2)醗酵過程の糖の添加時期を制御することでビフィズス菌を増殖させる技術(特許文献3)醗酵処理を2回に分けてビフィズス菌を増殖させる技術(特許文献4)などが挙げられる。しかし、ビフィズス菌以外の細菌が並存したり、特殊な風味から用途が限定されたり、製造管理上の高度な技術が要求されたり、製造コストを要したりすることから、未だ満足できる技術を見出すに至っていない。 Therefore, several techniques for obtaining an oral composition having a large number of viable bacteria have been proposed. For example, a technique of culturing mixed with Lactococcus lactis (Patent Document 1) A technique of promoting the growth of bifidobacteria using sweet potato and shochu (Patent Document 2) By controlling the timing of sugar addition in the fermentation process A technique for propagating bifidobacteria (patent document 3) A technique for propagating bifidobacteria by dividing the fermentation treatment into two steps (patent document 4) and the like. However, since bacteria other than Bifidobacteria coexist, the use is limited due to special flavors, advanced technology in production management is required, and production cost is required, it is still possible to find satisfactory technology It has not reached.
生菌状態のビフィズス菌を高濃度に含有する組成物を得るためのビフィズス菌醗酵方法および増殖方法を提供することを課題とする。従って、本発明の目的は、高度な製造技術を要求せず安価な原料を用いて、生菌状態のビフィズス菌を高濃度に含有する組成物を得るための汎用性の高いビフィズス菌醗酵方法および経口摂取による腸内におけるビフィズス菌の増殖方法、腸内細菌のフr−ラ改善方法ならびにそれらに使用する組成物を提供することにある。 It is an object of the present invention to provide a bifidobacteria fermentation method and a growth method for obtaining a composition containing a high concentration of bifidobacteria in a viable state. Accordingly, an object of the present invention is to provide a highly versatile bifidobacteria fermentation method for obtaining a composition containing a high concentration of bifidobacteria in a living bacterium state using an inexpensive raw material without requiring an advanced production technique and The object is to provide a method for proliferating bifidobacteria in the intestine by ingestion, a method for improving flora of intestinal bacteria, and a composition used therefor.
本発明者らは、かかる事情に鑑み鋭意検討を重ねた結果、驚くべきことにカボチャの破砕物等をビフィズス菌で醗酵処理することにより、ビフィズス菌の増殖が大幅に促進されるとともに生菌数が多いビフィズス菌醗酵物が得られること、およびビフィズス菌とカボチャ破砕物等を同時に経口摂取することにより腸内に存在するビフィズス菌の増殖を促進し、腸内細菌フローラにおけるビフィズス菌の存在割合を大きく増加させ、腸内フローラの改善ができることを見出し、本発明を完成するに至った。 As a result of intensive studies in view of such circumstances, the present inventors surprisingly fermented pumpkin crushed materials with bifidobacteria, thereby greatly promoting the growth of bifidobacteria and increasing the number of viable bacteria. The bifidobacteria fermented product with a large amount of Bifidobacteria can be obtained, and by simultaneously ingesting bifidobacteria and pumpkin crushed material, etc., the growth of bifidobacteria present in the intestine is promoted, It was greatly increased and the intestinal flora was found to be improved, and the present invention was completed.
すなわち、本発明は、項1ないし項6のビフィズス菌の増殖方法、増殖促進剤或いは醗酵物を提供するものである。
項1.下記の(A)または(B)のカボチャ処理物を含有する組成物を用いてビフィズス菌を増殖する方法。
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁
項2.下記の(A)または(B)のカボチャ処理物を含有する組成物からなるビフィズス菌の増殖促進剤。
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁
項3. 下記の(C)または(D)のカボチャ処理物を含有する組成物のビフィズス菌醗酵物。
(C)組成物全量に対して30質量%以上のカボチャ破砕物
(D)組成物全量に対して16質量%以上のカボチャ搾汁
項4.下記の(A)または(B)のカボチャ処理物とビフィズス菌とを含有する経口組成物を用いて腸内ビフィズス菌を増殖する方法。
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁
項5.下記の(A)または(B)のカボチャ処理物とビフィズス菌とを含有する経口組成物からなる腸内ビフィズス菌の増殖促進剤。
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁
項6. (A)または(B)のカボチャ処理物とビフィズス菌のみからなる経口組成物であることを特徴とする項5に記載の腸内ビフィズス菌の増殖促進剤。
That is, this invention provides the growth method of a bifidobacterium of claim | item 1 thru | or 6, the growth promoter, or a fermented product.
Item 1. A method for growing bifidobacteria using a composition containing a processed pumpkin of the following (A) or (B).
(A) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition A bifidobacteria growth promoter comprising a composition comprising the following processed pumpkin (A) or (B).
(A) Pumpkin crushed product of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition Item 3. Pumpkin processed product of the following (C) or (D) Bifidobacteria fermented product containing the composition.
(C) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (D) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition. A method for growing intestinal bifidobacteria using an oral composition containing the processed pumpkin (B) or bifidobacteria of (A) or (B) below.
(A) Pumpkin crushed product of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition An intestinal bifidobacteria growth promoter comprising an oral composition containing the following processed pumpkin (A) or (B) and bifidobacteria.
(A) Pumpkin crushed product of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition Item 6. Pumpkin processed product and bifido of (A) or (B) Item 6. The intestinal bifidobacteria growth promoter according to Item 5, which is an oral composition consisting of only bacteria.
本発明によれば、食品素材として種々の栄養素を豊富に含有し栄養価の高いカボチャを用いてビフィズス菌を増殖させることから、得られるビフィズス菌醗酵物はカボチャのビフィズス菌醗酵処理物であるとも言える。従って、本発明の方法で得られるビフィズス菌醗酵物は、生菌状態の高濃度ビフィズス菌のリソースとしてそのまま利用したり他の経口組成物に配合したりする事ができる。加えて、ビフィズス菌の醗酵処理によりカボチャが有する独特の風味も改善できることから、幅広い用途に適合できるカボチャ食品素材としても提供することができる。また、カボチャと生菌状態のビフィズス菌を同時に摂取すると、腸内のビフィズス菌を増殖させ、かつ腸内細菌におけるビフィズス菌の存在比率を高めることができることから、ビフィズス菌数を増加させ腸内菌叢を望ましい状態に近づけるための方法および当該方法に用いる経口組成物を提供することができる。 According to the present invention, since the bifidobacteria are proliferated using a pumpkin that is rich in various nutrients and has a high nutritional value as a food material, the obtained bifidobacteria fermentation product is a bifidobacteria fermentation product of pumpkin. I can say that. Therefore, the bifidobacteria fermented product obtained by the method of the present invention can be used as it is as a resource for high-concentration bifidobacteria in a living state or can be blended in other oral compositions. In addition, since the unique flavor of the pumpkin can be improved by the fermentation treatment of Bifidobacterium, it can also be provided as a pumpkin food material that can be adapted to a wide range of uses. In addition, ingesting pumpkin and viable Bifidobacterium at the same time can increase Bifidobacteria in the intestines and increase the ratio of Bifidobacteria in the intestinal bacteria. A method for bringing the flora closer to the desired state and an oral composition for use in the method can be provided.
本発明で用いるビフィズス菌は、グラム陽性無芽胞桿菌のビフィドバクテリウム属の細菌をいう。具体的には、ビフィドバクテリウム・ロンガム(Bifidobacterium longum)、ビフィドバクテリウム・ブレーベ(Bifidobacterium breve)、ビフィドバクテリウム・ビフィダム(Bifidobacterium bifidum)、ビフィドバクテリウム・インファンティス(Bifidobacterium infantis)、ビフィドバクテリウム・カテヌラタム(Bifidobakuterium catenulatum)、ビフィドバクテリウム・アドレセンティス(Bifidobacterium adolescentis)、ビフィドバクテリウム・シュードロンガム(Bifidobacterium pseudolongum)、ビフィドバクテリウム・アニマリス(Bifidobacterium animalis)などが挙げられる。この中でもビフィドバクテリウム・ロンガム(Bifidobacterium longum)、ビフィドバクテリウム・ブレーベ(Bifidobacterium breve)、ビフィドバクテリウム・ビフィダム(Bifidobacterium bifidum)、ビフィドバクテリウム・インファンティス(Bifidobacterium infantis)、ビフィドバクテリウム・アドレセンティス(Bifidobacterium adolescentis)が好ましく、ビフィドバクテリウム・ロンガム(Bifidobacterium longum)、ビフィドバクテリウム・ブレーベ(Bifidobacterium breve)、ビフィドバクテリウム・ビフィダム(Bifidobacterium infantis)がより好ましく、ビフィドバクテリウム・ロンガム(Bifidobacterium longum)が最も好ましい。これらのビフィドバクテリウム属の桿菌は、単独もしくは複数の菌を組み合わせて用いることができる。 The bifidobacteria used in the present invention refers to a bacterium belonging to the genus Bifidobacterium which is a Gram-positive sporeless bacterium. Specifically, Bifidobacterium longum , Bifidobacterium breve , Bifidobacterium bifidum , Bifidobacterium infantis , Bifidobacterium Katenuratamu (Bifidobakuterium catenulatum), Bifidobacterium address Sen Tisdale (Bifidobacterium adolescentis), Bifidobacterium shoe Delon gum (Bifidobacterium pseudolongum), Bifidobacterium animalis (Bifidobacterium animalis), and the like It is done. Among them, Bifidobacterium longum , Bifidobacterium breve , Bifidobacterium bifidum , Bifidobacterium infantis , Bifido Bifidobacterium adolescentis is preferred, Bifidobacterium longum , Bifidobacterium breve , Bifidobacterium infantis is more preferred, Bifidobacterium infantis Most preferred is Bifidobacterium longum . These Bifidobacterium spp. Can be used alone or in combination of a plurality of bacteria.
本発明で用いるカボチャ(南瓜)は、ウリ科カボチャ属(学名 Cucurbita)の一年草または多年草植物の果実を意味する。別名、ナンキン、トウナス(唐茄子)、南京瓜、南蛮瓜、ボウブラとも称される。カボチャの品種は、日本カボチャ(別称、東洋カボチャ:学名 Cucurbita moschata Duchesne ex Poir.)、西洋カボチャ(学名 Cucurbita maxima Duchesne ex Lam.)、ペポカボチャ(学名 Cucurbita pepo L.)、ミクスタ(別称、種間雑種:学名 Cucurbita mixta)に大別されるが、このうち日本カボチャおよび西洋カボチャが好ましく、西洋カボチャが最も好ましい。品種名としては、黒皮南瓜、小菊南瓜、三毛門南瓜、会津南瓜、菊座南瓜、鹿ヶ谷南瓜、縮緬南瓜、さくら南瓜、えびす南瓜、みやこ南瓜、味平南瓜、くりゆたか、打木赤皮栗南瓜、坊ちゃん南瓜、宿儺南瓜、芳香青皮栗南瓜、新土佐南瓜、会栗南瓜、平和親善南瓜、ターバン、デリシャス、ハッパード、ズッキーニ、花ズッキーニ、ミニズッキーニ、金糸瓜、コリンキー、バターナッツスカッシュ、エイコンスカッシュ、サマースカッシュ、スパゲッティスカッシュなどが挙げられる。本発明において、カボチャ(果実)を破砕処理して得られる「カボチャ破砕物」を用いることができるほか、カボチャやカボチャ破砕物を搾汁処理して得られる「カボチャ搾汁」も最適に用いることができる。前記「カボチャ破砕物」とは、カボチャやカボチャ破砕物などを破砕処理してピューレ状やペースト状としたものであり、さらに濃縮処理や乾燥処理を行った濃縮物や乾燥物も包含する。カボチャ破砕物は、例えば、カボチャの果実を必要に応じて破砕処理する前に加熱処理(ブランチングと呼ばれる)を行った後に、ハンマークラッシャー、電動ミル、コミトロール、マスコロイダー、フードプロセッサー、パルパーフィニッシャー等の破砕機や裏ごし機を用いて粉砕することで得られる。好ましいカボチャ破砕物は、破砕物全量に対して不溶性固形分量が30質量%以上のものを使用でき、40質量%以上のものが好ましく使用できる。ここで言う不溶性固形分量とは、果汁飲料の不溶性固形分分析法、すなわち試料10gを遠沈管に採取し、ローター半径14.5cmの遠心分離機を用いて、毎分3000回転、10分間遠心分離を行い、上清部と沈殿部を分けて質量測定し、沈殿部分の質量パーセントを測定する事により得られる数値である。流動性が悪く前記遠心分離の条件では分離しにくい場合は、精製水により正確に2倍希釈して均一分散した試料を遠心分離し、沈殿物の質量%を2倍して不溶性固形分量とすることにより測定することも可能である。前記「カボチャ搾汁」とは、カボチャを必要に応じて加熱処理(ブランチングと呼ばれる)した後にそのまま圧搾処理したり、前記の破砕物を連続遠心分離機やろ過機などを用いた固液分離処理して、カボチャ破砕物の固形分の一部またはすべてを除去し液状にした組成物や、破砕物に適量の精製水を添加し必要に応じて加熱しつつ十分に攪拌した後に固液分離処理して得られる搾汁や、搾汁液を濃縮処理した搾汁濃縮物、乾燥させた粉末等形状の搾汁乾燥物を包含するものである。以下において記載する「カボチャ破砕物等」とは、前記で規定する「カボチャ破砕物」及び「カボチャ搾汁」の両方を包含する。 The pumpkin (nanban) used in the present invention means a fruit of an annual or perennial plant of the genus Cucurbita (scientific name: Cucurbita ). Also known as Nankin, Tounas, Nanjing, Nanban and Bowbra. Pumpkin varieties include Japanese pumpkin (also known as Oriental pumpkin: scientific name Cucurbita moschata Duchesne ex Poir. ), Western pumpkin (scientific name Cucurbita maxima Duchesne ex Lam. ), Pepo pumpkin (scientific name Cucurbita pepo L. ), Mikusta (also known as interspecific hybrids). : Scientific name Cucurbita mixta ), of which Japanese pumpkin and western pumpkin are preferred, and western pumpkin is most preferred. The names of the varieties are: black skinned Nanko, Kogiku Nanto, Sangemon Nanto, Aizu Nanto, Kikuza Nanto, Shikagaya Nanto, Chiba Nanto, Sakura Nanto, Ebisu Nanto, Miyako Nanto, Minehira Nanto, Kuriyutaka, Uchigi Red Skin Chinan-an, Bo-chan Nan-an, Sukuto-nan-an, Fragrance Blue Skin Chin-an, Shintosa Nan-an, Kai-ri Nan-an, Peaceful Goodwill Nan-an, Turban, Delicious, Happard, Zucchini, Hana Zucchini, Mini Zucchini, Gold Thread, Collinky, Butternut Squash, Akon squash, summer squash, spaghetti squash and the like. In the present invention, “pulverized pumpkin” obtained by crushing pumpkins (fruits) can be used, and “pumpkin juice” obtained by squeezing pumpkins and crushed pumpkins can also be used optimally. Can do. The “pumpkin crushed material” is a product obtained by crushing a pumpkin or a pumpkin crushed material to form a puree or paste, and further includes a concentrated product or a dried product obtained by performing a concentration treatment or a drying treatment. The pumpkin crushed material is, for example, heat treated (called blanching) before crushing the pumpkin fruit as necessary, then hammer crusher, electric mill, comitroll, mascolloider, food processor, pulper finisher It can be obtained by crushing using a crusher such as The preferable pumpkin crushed material can use the thing whose insoluble solid content amount is 30 mass% or more with respect to the crushed material whole quantity, and a 40 mass% or more thing can use it preferably. The insoluble solid content mentioned here is an insoluble solid content analysis method for fruit juice beverages, that is, 10 g of a sample is collected in a centrifuge tube and centrifuged at 3000 rpm for 10 minutes using a centrifuge with a rotor radius of 14.5 cm. This is a numerical value obtained by measuring the mass of the supernatant part and the precipitation part separately and measuring the mass percentage of the precipitation part. If the fluidity is poor and difficult to separate under the above-mentioned conditions of centrifugation, the sample that has been diluted with purified water exactly twice and uniformly dispersed is centrifuged, and the mass% of the precipitate is doubled to obtain an insoluble solid content. It is also possible to measure by this. The “pumpkin juice” means that the pumpkin is subjected to a heat treatment (called blanching) as needed, and then pressed as it is, or the crushed material is separated into solid and liquid using a continuous centrifuge or a filter. After removing some or all of the solid content of the pumpkin crushed material, the composition was made liquid, or after adding a suitable amount of purified water to the crushed material and heating it as necessary, it was stirred and solid-liquid separated. The squeezed juice obtained by processing, a squeezed concentrate obtained by concentrating the squeezed liquid, and a dried squeezed product having a shape such as dried powder are included. “Pumpkin crushed material and the like” described below includes both “pumpkin crushed material” and “pumpkin juice” defined above.
ビフィズス菌を用いた醗酵は、以下に例示する方法などにより行うことができる。なお、「被醗酵物」とは、ビフィズス菌の増殖時、すなわちビフィズス菌醗酵処理時において、ビフィズス菌を接種する時点(スターターを使用する場合はスターター添加時)における被醗酵処理物を意味する。 Fermentation using bifidobacteria can be performed by a method exemplified below. The “fermented product” means a fermented product at the time of inoculation of bifidobacteria during the growth of bifidobacteria, that is, during the bifidobacteria fermentation treatment (when a starter is used).
ビフィズス菌を用いた醗酵を行う前に、必要に応じてカボチャ破砕物等へ適宜精製水を添加することができる。例えば、乾燥物や濃縮処理したカボチャ破砕物等を使用する場合には、濃縮・乾燥処理前のカボチャ破砕物等と同様な状態とするために精製水を添加して乾燥物や濃縮処理したカボチャ破砕物等を溶解・分散させることができる。また、特に、カボチャ破砕物等において、醗酵処理の観点から粘度が高すぎる場合や、醗酵処理装置の構造上の理由から被醗酵物の粘度を低下させる必要が存在する場合、醗酵処理前に予め精製水、カボチャ以外の野菜搾汁、果汁等の本願発明の効果を損なわない程度の液体成分をカボチャ破砕物等に添加し、醗酵処理を行うに適正な粘度に調整した上でビフィズス菌を用いた醗酵に供することができる。なお、カボチャ破砕物等に他成分を添加する場合、添加する量は特定するものではないが、濃縮・乾燥処理を行っていないカボチャ破砕物等に換算したときのカボチャ破砕物等の質量よりすくない添加量に設定すると、本願発明の所期の効果を得られ易いため好ましい。すなわち、ビフィズス菌を用いて醗酵させる被醗酵物の50質量%以上が濃縮・乾燥処理を行っていないカボチャ破砕物等であることが好ましい。さらには75質量%以上が濃縮・乾燥処理を行っていないカボチャ破砕物等であることが好ましく、他の成分を混合することなくビフィズス菌を用いた醗酵に供することが最も好ましい。また、従来、ビフィズス菌の被醗酵物として使用されている、乳、ホエイ、アブラナ科植物の破砕物等、果汁などをカボチャ破砕物等に混合した組成物をビフィズス菌を用いた醗酵処理の被醗酵物として供することもできる。但し、この場合において、濃縮等の処理を行っていないカボチャ破砕物の場合、カボチャ破砕物の被醗酵物全量に対する含有量は30質量%以上であることが好ましく、40重量%以上であることが更に好ましく、50質量%以上であることが最も好ましい。カボチャ破砕物を濃縮・乾燥処理して得られたカボチャ破砕物の濃縮物や乾燥物を用いる場合は、各々の処理を行う前のカボチャ破砕物の質量に換算したときの含有量が前記で規定する被醗酵物全量に対する含有量となるようにする。また、濃縮等の処理を行っていないカボチャ搾汁の場合、搾汁の被醗酵物全量に対する含有量は、12質量%以上であることが好ましく、16重量%以上であることが更に好ましく、20質量%以上であることが最も好ましい。カボチャ搾汁の濃縮・乾燥処理して得られたカボチャ搾汁の濃縮物や乾燥物を用いる場合は、各々の処理を行う前のカボチャ搾汁の質量に換算したときの含有量が前記で規定する被醗酵物全量に対する含有量となるようにする。 Before performing fermentation using bifidobacteria, purified water can be appropriately added to the pumpkin crushed material and the like as necessary. For example, when using a dried product or a crushed pumpkin that has been subjected to a concentration treatment, purified water is added and the dried product or a pumpkin that has been subjected to a concentration treatment in order to obtain a state similar to that of the crushed pumpkin before concentration / drying processing It can dissolve and disperse crushed materials. In particular, in pumpkin crushed materials, etc., if the viscosity is too high from the viewpoint of fermentation treatment, or if there is a need to reduce the viscosity of the fermented material for structural reasons of the fermentation treatment device, before the fermentation treatment Add liquid components that do not impair the effects of the present invention, such as purified water, vegetable juice other than pumpkin, fruit juice, etc., to pumpkin crushed materials, etc., and adjust the viscosity to the appropriate value for fermentation treatment, then use bifidobacteria It can be used for fermentation. In addition, when adding other components to pumpkin crushed materials, etc., the amount to be added is not specified, but it is less than the mass of pumpkin crushed materials, etc. when converted to pumpkin crushed materials that have not been concentrated or dried. It is preferable to set the addition amount because the desired effect of the present invention can be easily obtained. That is, it is preferable that 50% by mass or more of the fermented product to be fermented with bifidobacteria is a pumpkin crushed material that has not been subjected to concentration / drying treatment. Furthermore, 75% by mass or more is preferably pumpkin crushed material that has not been subjected to concentration / drying treatment, and most preferably subjected to fermentation using bifidobacteria without mixing other components. In addition, a composition obtained by mixing milk juice, whey, cruciferous plants, fruit juice, etc., with pumpkin crushed materials, etc., which is conventionally used as a fermented product of bifidobacteria, is subjected to fermentation treatment using bifidobacteria. It can also be used as a fermentation product. However, in this case, in the case of a pumpkin crushed product that has not been subjected to treatment such as concentration, the content of the pumpkin crushed product with respect to the total amount of the fermented product is preferably 30% by mass or more, and more preferably 40% by weight or more. More preferably, it is most preferably 50% by mass or more. When using a concentrated or dried pumpkin crushed product obtained by concentrating and drying pumpkin crushed material, the content when converted to the mass of the pumpkin crushed material before each treatment is specified above. It is made to become content to the to-be-fermented product whole quantity to do. Moreover, in the case of pumpkin juice that has not been subjected to processing such as concentration, the content of the juice with respect to the total amount of the fermentation product is preferably 12% by mass or more, more preferably 16% by weight or more, and 20 Most preferably, it is at least mass%. When using a pumpkin juice concentrate or dried product obtained by concentration and drying of pumpkin juice, the content when converted to the mass of the pumpkin juice before each treatment is specified above. It is made to become content to the to-be-fermented product whole quantity to do.
ビフィズス菌を用いた醗酵は、前記のカボチャ破砕物等にビフィズス菌のスターターを接種することで開始する。ビフィズスのスターターは、常法を用いて調製することができ、スターターの性状、組成などに特に制限はない。本発明で用いるビフィズス菌のスターターの形態としては、液状、凍結状、粉末状とすることができる。但し、液状以外のスターターを使用する場合は、接種前に精製水やスターターの被醗酵物を用いて液状としてから接種することが好ましい。なお、カボチャ以外の成分を添加しないカボチャ破砕物等を用いてスターターを調製する場合、均一な醗酵を行うため、予めカボチャ破砕物等に水を添加して適正な粘度に調整することもできる。但し、水を添加する場合、不溶性固形分量が5質量%以上とすることが必要である。好ましく使用できるビフィズス菌のスターターは、接種時のスターター1gあたり、少なくとも10の8乗個以上、より好ましくは10の9乗個以上の生菌状態のビフィズス菌を含んでいることが必要である。
スターターの接種時の添加量は、特に限定するものではないが、通常、被醗酵物1グラムあたり少なくとも10の6乗個以上、好ましくは10の7乗個の生菌状態のビフィズス菌となるようなスターターの量とする。 予め接種時(被醗酵物へのスターター添加時)のカボチャ破砕物等の温度は30〜43℃の範囲であれば特に制限されるものではないが、35〜42℃が好ましく、36〜40℃がもっとも好ましい。醗酵時のカボチャ破砕物等の温度は、18〜45℃とする。中でも25〜42℃の温度領域で醗酵させることが好ましく、35〜42℃の温度領域がもっとも好ましい。ビフィズス菌を用いた醗酵処理時間は醗酵時の温度条件などにより適宜調整されるが、通常6〜30時間であり、好ましくは8〜26時間である。
Fermentation using bifidobacteria starts by inoculating the starter of bifidobacteria on the pumpkin crushed material or the like. The bifidus starter can be prepared using conventional methods, and there are no particular restrictions on the properties and composition of the starter. The form of the starter of bifidobacteria used in the present invention may be liquid, frozen or powder. However, when using a starter other than liquid, it is preferable to inoculate after using purified water or a fermented product of starter before inoculation. In addition, when preparing a starter using the pumpkin crushed material etc. which do not add components other than a pumpkin, in order to perform uniform fermentation, water can be previously added to a pumpkin crushed material etc., and it can also adjust to an appropriate viscosity. However, when water is added, the insoluble solid content must be 5% by mass or more. The Bifidobacterium starter which can be preferably used should contain at least 10 8 or more, more preferably 10 9 or more Bifidobacteria per gram of starter at the time of inoculation.
The addition amount at the time of inoculation of the starter is not particularly limited, but usually, it becomes at least 10 6 or more, preferably 10 7 7 viable Bifidobacteria per gram of the fermented product. The amount of starter. The temperature of the pumpkin crushed material at the time of inoculation (when adding the starter to the fermented product) is not particularly limited as long as it is in the range of 30 to 43 ° C, but preferably 35 to 42 ° C, and 36 to 40 ° C. Is most preferred. The temperature of the crushed pumpkin etc. at the time of fermentation shall be 18-45 degreeC. Among these, fermentation is preferably performed in a temperature range of 25 to 42 ° C, and a temperature range of 35 to 42 ° C is most preferable. The fermentation treatment time using the bifidobacteria is appropriately adjusted depending on the temperature conditions at the time of fermentation, etc., but is usually 6 to 30 hours, preferably 8 to 26 hours.
前記醗酵処理時において、ビフィズス菌以外の細菌の増殖を抑制する目的で、適宜少量の緑茶カテキンに代表される植物抽出物等をビフィズス菌被醗酵物に添加することができる。これらの添加量は、たとえば緑茶カテキンでは0.01〜0.2質量%である。また、ビフィズス菌の増殖をさらに向上させるためにブドウ糖などの糖質を添加することもできる。糖質の添加量は、被醗酵物に対し0.1〜10質量%である。さらにビフィズス菌醗酵時のpH制御を目的として、pH調整剤の添加も可能である。ビフィズス菌醗酵に適したpH調整剤としては、酢酸ナトリウム、リン酸三カリウム、リン酸水素二カリウム、リン酸二水素カリウムが挙げられるが、pH緩衝作用を有するものであればこれらに限定されるものではない。pH調整剤の添加量は、被醗酵物に対し0.01〜1質量%である。 At the time of the fermentation treatment, a small amount of a plant extract typified by green tea catechin can be added to the Bifidobacterium-fermented product for the purpose of suppressing the growth of bacteria other than Bifidobacterium. These addition amounts are 0.01-0.2 mass% in green tea catechin, for example. Moreover, in order to further improve the growth of bifidobacteria, sugars such as glucose can be added. The addition amount of saccharides is 0.1-10 mass% with respect to a fermented material. Furthermore, a pH adjuster can be added for the purpose of pH control during fermentation of bifidobacteria. Examples of pH adjusters suitable for Bifidobacteria fermentation include sodium acetate, tripotassium phosphate, dipotassium hydrogen phosphate, and potassium dihydrogen phosphate, but are limited to these as long as they have a pH buffering action. It is not a thing. The addition amount of a pH adjuster is 0.01-1 mass% with respect to a fermented material.
発明のビフィズス菌醗酵処理を行って得られた醗酵物は、ビフィズス菌の生菌率を低下させない限り、様々な形態で使用しうる。例えば、本願の方法で得られる醗酵物を固形化し、そのまま、或いは他の固形物と混合したものを、粉末化加工、顆粒化加工、カプセル充填加工、錠剤/タブレット化加工することにより、経口組成物やヨーグルトなどの自家醗酵用のスターター、食品・医薬品等の原料などとして使用することができる。また、本願の方法で得られる醗酵物に他の原料や化合物を配合して経口組成物として使用したり、被醗酵物に必要な原料を予め配合しておくことで、本願の方法の醗酵処理を行い得られたものをそのまま経口組成物として使用することもできる。カボチャの破砕物(固形物の残存程度の選択も含む)若しくは搾汁の選択については、醗酵処理後のビフィズス菌の生菌量もしくは生菌率、醗酵処理後の加工内容、カボチャ以外の被醗酵物の存在の有無、カボチャの不溶性固形分が有する生理機能等の活用の有無などを勘案したうえで、適宜選択することが好ましい。 The fermented product obtained by performing the bifidobacteria fermentation treatment of the invention can be used in various forms as long as the viable bacteria rate of the bifidobacteria is not reduced. For example, the fermented product obtained by the method of the present application is solidified and directly or mixed with other solids, and then powdered, granulated, capsule-filled, or tablet / tablet processed to produce an oral composition It can be used as a starter for in-house fermentation such as food and yogurt, and as a raw material for foods and pharmaceuticals. In addition, the fermented product obtained by the method of the present application can be used as an oral composition by blending other raw materials and compounds, or the necessary raw materials for the fermented product can be blended in advance, so that the fermentation treatment of the method of the present application can be performed. What was obtained by performing can also be used as an oral composition as it is. About selection of crushed pumpkin (including selection of remaining degree of solid matter) or juice, viable amount or viability of bifidobacteria after fermentation treatment, processing content after fermentation treatment, fermentation other than pumpkin It is preferable to select as appropriate in consideration of the presence or absence of a substance, the presence or absence of utilization of the physiological function of the insoluble solid content of the pumpkin, and the like.
本発明のビフィズス菌の醗酵処理に用いる被醗酵物またはビフィズス菌の醗酵物には、本願効果を損なわない範囲でカボチャ以外の通常経口組成物に使用される食品原料や化合物を必要に応じて適宜配合することができる。 For the fermented product used for the fermentation treatment of bifidobacteria of the present invention or the fermented product of bifidobacteria, food raw materials and compounds used in normal oral compositions other than pumpkins are appropriately selected as needed within a range not impairing the effect of the present application. Can be blended.
配合できる成分としては、例えば、りんご果汁など柑橘類以外の果汁、果実ピューレ、果実さのう;カボチャ以外の野菜の搾汁、エキス、破砕物、ペースト;甘味料(ショ糖、ぶどう糖、果糖、乳糖、スクラロース、アスパルテーム、アセスルファムカリウム、ステビア抽出物など);糖アルコール類(還元麦芽糖水飴、マルチトール、キシリトール、ソルビトール、エリスリトールなど);オリゴ糖類(ラクチュロース、フラクトオリゴ糖、ガラクトオリゴ糖、イソマルトオリゴ糖、ラフィノース、パラチノースオリゴ糖、キシロオリゴ糖など);甘味料(サッカリン、サッカリンナトリウム、アセスルファムカリウム、ステビアエキス、ステビオサイド、スクラロース、ネオヘスペリジルジヒドロカルコン、グリチルリチン、ペリラルチン、ソウマチン、アスパルチルフェニルアラニンメチルエステル、メトキシシンナミックアルデヒド、トレハロース、エリスリトール、ソルビトール、パラチノース、パラチニット、キシリトール、マルトース、ラクチトール、フルクトース、還元パラチノース、グルコース、砂糖、三温糖、精製はちみつ、未精製はちみつ、還元水飴、水飴、異性化糖(ブドウ糖果糖液糖、果糖ブドウ糖液糖など));酸味料(クエン酸、グルコン酸、りんご酸、酒石酸などの果実酸類、酢酸、乳酸、リン酸、コハク酸、グルタミン酸など);強化剤(L−アスコルビン酸、チアミン塩酸塩、リボフラビン、ピリドキシン塩酸塩、カロテン、α−トコフェロール、コレカルシフェロール、乳酸カルシウム、グルコン酸カルシウム、炭酸カルシウム、水酸化カルシウム、酸化マグネシウム、水酸化マグネシウム、塩化マグネシウム、グルコン酸亜鉛、クエン酸第一鉄アンモニウム、ピロリン酸第二鉄など);増粘多糖類(ペクチン、カラギーナン、グアガム、アラビアガム、ローカストビーンガム、アルギン酸塩、キサンタンガム、大豆多糖類、ジェランガム、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、結晶セルロース、粉末セルロース、カルボキシメチルセルロース、エチルセルロース、メチルセルロースなど);その他の成分(色素、酸化防止剤、水溶性食物繊維、不溶性食物繊維、動植物エキス、アミノ酸、たんぱく質加水分解ペプチド、トレハロース、シクロデキストリン、キトサン、ヒアルロン酸、フィチン酸、酵母エキス、ビタミン類、ミネラル類、香料)などが挙げられる。 Ingredients that can be blended include, for example, fruit juices other than citrus fruits such as apple juice, fruit puree, fruit sauna; juices, extracts, crushed products, pastes of vegetables other than pumpkins; sweeteners (sucrose, glucose, fructose, lactose Sugar alcohols (reduced maltose starch syrup, maltitol, xylitol, sorbitol, erythritol, etc.); oligosaccharides (lactulose, fructooligosaccharides, galactooligosaccharides, isomaltoligosaccharides, raffinose, sucralose, aspartame, acesulfame potassium, stevia extract, etc.) Palatinose oligosaccharides, xylooligosaccharides, etc .; sweeteners (saccharin, saccharin sodium, acesulfame potassium, stevia extract, stevioside, sucralose, neohesperidyl dihydrochalcone, glycyrrhizin, perilartin Saumatine, aspartylphenylalanine methyl ester, methoxycinnamic aldehyde, trehalose, erythritol, sorbitol, palatinose, palatinite, xylitol, maltose, lactitol, fructose, reduced palatinose, glucose, sugar, trithermal sugar, purified honey, unrefined honey, reduced Chickenpox, chickenpox, isomerized sugar (glucose fructose liquid sugar, fructose glucose liquid sugar, etc.); acidulants (fruit acids such as citric acid, gluconic acid, malic acid, tartaric acid, acetic acid, lactic acid, phosphoric acid, succinic acid, glutamic acid Reinforcing agent (L-ascorbic acid, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, carotene, α-tocopherol, cholecalciferol, calcium lactate, calcium gluconate, calcium carbonate, calcium hydroxide , Magnesium oxide, magnesium hydroxide, magnesium chloride, zinc gluconate, ferrous ammonium citrate, ferric pyrophosphate, etc.); thickening polysaccharides (pectin, carrageenan, guar gum, gum arabic, locust bean gum, alginic acid) Salt, xanthan gum, soybean polysaccharide, gellan gum, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, crystalline cellulose, powdered cellulose, carboxymethylcellulose, ethylcellulose, methylcellulose, etc .; other ingredients (pigment, antioxidant, water-soluble dietary fiber) , Insoluble dietary fiber, animal and plant extracts, amino acids, protein hydrolyzed peptides, trehalose, cyclodextrin, chitosan, hyaluronic acid, phytic acid, yeast extract, vitamins , Minerals, and fragrances).
また、本願発明は腸内のビフィズス菌を増殖させ、腸内細菌フローラを改善させ、さらにはおなかの調子を整える目的でも使用できる。具体的には、前記カボチャ搾汁及び/またはカボチャ破砕物とビフィズス菌を含有する組成物を経口摂取することで、腸内に存在するビフィズス菌を増殖したり、腸内細菌におけるビフィズス菌の存在比率を高め、本来望ましいとされる腸内細菌フローラに近づける若しくは実現させることができる。腸内のビフィズス菌を増殖させる方法に用いる経口組成物において使用するカボチャ搾汁及び/またはカボチャ破砕物は乾燥物であることが、経口組成物の品質保持期間を大幅に向上させることができるため好ましい。当該経口組成物においてカボチャ破砕物を用いる場合は経口組成物全量に対して30質量%以上、カボチャ破砕物の替わりにカボチャ搾汁を用いる場合は経口組成物全量に対して16質量%以上含有させることが好ましい。当然、両者を混合して使用しても良い。その場合の各々の配合量は、「カボチャ破砕物は経口組成物全量に対して30質量%」を100としたときのカボチャ破砕物配合量に相当する相対値(A)、「カボチャ搾汁は経口組成物全量に対して16質量%」を100としたときのカボチャ搾汁の配合量に相当する相対値(B)としたとき、(A)と(B)の合計値が100を超えるように各々の配合量を調整することが好ましい。一方、ビフィズス菌については、経口組成物中に生菌状態で存在することが必要である、特に限定するものではないが、1回に摂取する経口組成物全量中に1*108C.F.U.以上存在することが好ましい。 The present invention can also be used for the purpose of growing bifidobacteria in the intestine, improving the intestinal bacterial flora, and adjusting the condition of the stomach. Specifically, by ingesting the pumpkin juice and / or the composition containing the pumpkin crushed material and bifidobacteria, the bifidobacteria present in the intestines are propagated, or the presence of bifidobacteria in the intestinal bacteria The ratio can be increased and brought closer to or realized in the intestinal bacterial flora that is originally desirable. The pumpkin juice and / or pumpkin crushed material used in the oral composition used in the method for growing Bifidobacteria in the intestine can be greatly improved in the quality retention period of the oral composition because it is a dry product. preferable. When using a pumpkin crushed material in the oral composition, it is 30% by mass or more based on the total amount of the oral composition. When using a pumpkin juice instead of the pumpkin crushed material, it is contained at least 16% by mass based on the total amount of the oral composition. It is preferable. Of course, both may be used in combination. In this case, each blending amount is “Relative value (A) corresponding to the blended amount of pumpkin crushed product when 100% of the pumpkin crushed product is 30% by mass with respect to the total amount of the oral composition”, “Pumpkin juice is When the relative value (B) corresponding to the blended amount of pumpkin juice when “16% by mass” is set to 100 with respect to the total amount of the oral composition, the total value of (A) and (B) exceeds 100. It is preferable to adjust each compounding amount. On the other hand, bifidobacteria need to be present in the oral composition in a viable state. Although not particularly limited, 1 * 10 8 CFU or more exists in the total amount of the oral composition taken at one time. It is preferable to do.
以下、本発明を具体的に説明するが、本発明は下記の例に限定されるものではない。なお、以下特に断りのない限り「%」は「質量%」を示す。 Hereinafter, the present invention will be specifically described, but the present invention is not limited to the following examples. In the following, “%” means “mass%” unless otherwise specified.
ビフィズス菌の増殖促進効果の評価
ビフィズス菌の増殖促進効果について下記の方法に従い評価した。
(被評価物の調製)
西洋カボチャを裁断し、コミトロールを用いてカボチャ破砕物を調製した。得られたカボチャ破砕物を遠心分離処理(機器名himac CR21G;日立工機(株)社製);8000r.p.m.,室温、10分)を行い、上澄を得た。この上澄を滅菌フィルター(0.45μm)を用いて除菌処理したものを評価に使用する「カボチャ搾汁」とした。
(供試菌株について)
下記のビフィズス菌について評価を行なった。
ビフィドバクテリウム・ロンガム(Bifidobacterium longum JCM1217:表1および2では「BL」と記載する。)
ビフィドバクテリウム・アドレセンティス(Bifidobacterium adolescentis JCM1275:表1では「BA」と記載する。)
ビフィドバクテリウム・インファンティス(Bifidobacterium infantis JCM1222:表1では「BI」と記載する。)
ビフィドバクテリウム・ブレーベ(Bifidobacterium breve JCM1192:表1では「BB」と記載する。)
(接種ビフィズス菌の調製方法について)
変法GAM寒天「ニッスイ」(日水製薬(株)社製)に各菌株を播種し、37℃、24時間、嫌気条件下(アナエロパック使用、三菱瓦斯(株)社製)で培養し、得られたコロニーを1白金耳採取し、各々、変法GAMブイヨン「ニッスイ」(日水製薬(株)社製)に接種し、37℃、24時間、嫌気条件下(アナエロパック使用、三菱瓦斯(株)社製)で培養を行った。培養後の菌液を「ビフィズス菌培養液」とした。
(評価試験方法について)
変法GAMブイヨン「ニッスイ」(日水製薬(株)社製)75質量部に、前記で調製したカボチャ搾汁若しくは除菌した精製水を25質量部加え、均一にした後、前記方法で調製した接種用の「ビフィズス菌培養液」を被醗酵物全量に対して初期の濁度が0.05〜0.1(620nm)の範囲となるよう、1〜5質量%添加し、初期の濁度(T0、C0:620nm)を測定した。測定後、37℃、24時間、嫌気条件下(アナエロパック使用、三菱瓦斯(株)社製)で培養を行い、培養直後の濁度(T24、C24:620nm)を測定した。
増殖促進倍率は下記式に従って算出した。得られた結果を表1に示した
増殖促進倍率=((T24−T0))/(C24−C0)
T0:培養開始時の試験培養液の濁度(620nm)
T24:培養終了直後の試験培養液の濁度(620nm)
T0:培養開始時の対照培養液の濁度(620nm)
C24:培養終了直後の対照培養液の濁度(620nm)
Evaluation of the growth promoting effect of bifidobacteria The growth promoting effect of bifidobacteria was evaluated according to the following method.
(Preparation of evaluation object)
Western pumpkins were cut and pumpkin crushed material was prepared using commitolol. The resulting pumpkin crushed material was subjected to a centrifugal separation process (device name: himac CR21G; manufactured by Hitachi Koki Co., Ltd.); 8000 rpm, room temperature, 10 minutes) to obtain a supernatant. The supernatant was sterilized using a sterilizing filter (0.45 μm) and used as a “pumpkin juice” used for evaluation.
(About the test strain)
The following bifidobacteria were evaluated.
Bifidobacterium longum ( Bifidobacterium longum JCM1217: described as “BL” in Tables 1 and 2)
Bifidobacterium adolescentis JCM1275 (described as “BA” in Table 1)
Bifidobacterium infantis ( Bifidobacterium infantis JCM1222: described as “BI” in Table 1)
Bifidobacterium breve ( Bifidobacterium breve JCM1192: described as “BB” in Table 1)
(About preparation method of inoculated bifidobacteria)
Modified GAM agar “Nissui” (manufactured by Nissui Pharmaceutical Co., Ltd.) was inoculated with each strain, and cultured at 37 ° C. for 24 hours under anaerobic conditions (anaeropack used, manufactured by Mitsubishi Gas Co., Ltd.) One platinum loop of the obtained colonies was collected and inoculated into a modified GAM bouillon “Nissui” (manufactured by Nissui Pharmaceutical Co., Ltd.), and at 37 ° C. for 24 hours under anaerobic conditions (anaeropack use, Mitsubishi Gas) (Manufactured by Co., Ltd.). The bacterial solution after the culture was referred to as “Bifidobacterium culture solution”.
(Evaluation test method)
25 parts by weight of the modified GAM bouillon “Nissui” (manufactured by Nissui Pharmaceutical Co., Ltd.) and 25 parts by weight of the pumpkin juice prepared or sterilized purified water were added and made uniform. 1 to 5% by mass of the inoculated “Bifidobacteria culture solution” is added so that the initial turbidity is in the range of 0.05 to 0.1 (620 nm) with respect to the total amount of the fermented product. The degree (T0, C0: 620 nm) was measured. After the measurement, the cells were cultured under anaerobic conditions (using Anaeropack, manufactured by Mitsubishi Gas Co., Ltd.) at 37 ° C. for 24 hours, and the turbidity (T24, C24: 620 nm) immediately after the cultivation was measured.
The multiplication promotion factor was calculated according to the following formula. The results obtained are shown in Table 1.
Growth promotion factor = ((T24−T0)) / (C24−C0)
T0: Turbidity of test culture solution at the start of culture (620 nm)
T24: Turbidity (620 nm) of the test culture immediately after completion of the culture
T0: Turbidity of control culture solution at the start of culture (620 nm)
C24: Turbidity (620 nm) of the control culture immediately after the end of the culture
表1に示したとおり、ビフィドバクテリウム・ロンガム(27.95)、ビフィドバクテリウム・アドレセンティス(3.27)、ビフィドバクテリウム・インファンティス(14.23)、ビフィドバクテリウム・ブレーベ(15.54)において、カボチャ破砕物は優れた増殖促進効果を示すことがわかった。またビフィズス菌の菌種により、その効果の程度が相違し、ビフィドバクテリウム・ロンガム、ビフィドバクテリウム・インファンティス、ビフィドバクテリウム・ブレーベにおいて優れた効果を示し、ビフィドバクテリウム・ロンガムに対して最も優れた効果を示すことがわかった。 As shown in Table 1, Bifidobacterium longum (27.95), Bifidobacterium adrecentis (3.27), Bifidobacterium infantis (14.23), Bifidobacterium -In breve (15.54), it turned out that a pumpkin crushed material shows the outstanding growth promotion effect. In addition, the degree of the effect varies depending on the species of Bifidobacterium, showing excellent effects in Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium It was found to have the most excellent effect on longum.
ビフィズス菌の生菌残存効果の評価
ビフィズス菌の生菌残存効果について下記の方法に従い評価した。
(被評価物の調製)
「カボチャ破砕物」としては、西洋カボチャを裁断し、コミトロールを用いて破砕したものを使用した。「リンゴ破砕物」としては、リンゴピューレ(長野興農(株)社製)を使用した。両破砕物については、90℃、10分間にて加熱処理を行い、常温に戻したものを使用した。対照としては、Difco MRS Broth(ベクトンディッキンソン社製、表では「MRS」と記載する。)および、前記MRS寒天培地にL−システインを0.05質量%添加したもの(表では「MRS+」と記載する。)
(供試菌株について)
ビフィズス菌は、ビフィドバクテリウム・ロンガム(Bifidobacterium longum JCM1217)を用いた。
(接種ビフィズス菌の調製方法について)
上記評価に記載した方法で調製した接種用の「ビフィズス菌培養液」を使用した。
(評価試験方法について)
前記で調製した被評価物及び対照物に、前記方法で調製した接種用の「ビフィズス菌培養液」を被醗酵物全量に対して2質量%添加し、37℃、24時間、嫌気条件下(アナエロパック使用、三菱瓦斯(株)社製)で培養した。培養後、1ml若しくは1g分取し、9mlの生理食塩水を用いて均一になるまで十分に攪拌した。攪拌後、正確に1ml分取し、9mlの生理食塩水を加えて十分に攪拌した。この処理を繰り返し行い、段階希釈した。段階希釈した各々から正確に100μlを分取後、MRS寒天培地(ベクトンディッキンソン社製)に塗抹し、37℃、48時間、嫌気条件下(アナエロパック使用、三菱瓦斯(株)社製)で培養した。段階希釈した各濃度において、コロニーの有無を目視で確認し、コロニーを確認できたもののうち最も希釈倍率が高いもののコロニー数をカウントし、その結果よりビフィズス菌の生菌数とした。結果を表2に示した。
Evaluation of the survival effect of bifidobacteria The survival effect of bifidobacteria was evaluated according to the following method.
(Preparation of evaluation object)
As the “pumpkin crushed material”, a western pumpkin was cut and crushed using a comitoroll. As the “broken apple”, apple puree (manufactured by Nagano Kono Co., Ltd.) was used. About both crushed materials, what heated to 90 degreeC and 10 minutes, and returned to normal temperature was used. As a control, Difco MRS Broth (manufactured by Becton Dickinson Company, described as “MRS” in the table) and 0.05% by mass of L-cysteine added to the MRS agar medium (“MRS +” in the table) (Describe)
(About the test strain)
Bifidobacterium longum ( Bifidobacterium longum JCM1217) was used as the Bifidobacterium .
(About preparation method of inoculated bifidobacteria)
“Bifidobacteria culture solution” for inoculation prepared by the method described in the above evaluation was used.
(Evaluation test method)
2% by mass of the “bifidobacteria culture solution” for inoculation prepared by the above method is added to the to-be-evaluated product and the control product prepared above, and the anaerobic condition is maintained at 37 ° C. for 24 hours ( The culture was performed using Anaeropack, manufactured by Mitsubishi Gas Co., Ltd.). After culturing, 1 ml or 1 g was taken and sufficiently stirred using 9 ml of physiological saline until uniform. After stirring, 1 ml was accurately taken and 9 ml of physiological saline was added and stirred sufficiently. This process was repeated and serially diluted. After exactly 100 μl was taken from each serially diluted solution, it was smeared on MRS agar medium (Becton Dickinson) and cultured under anaerobic conditions (anaeropack used, Mitsubishi Gas Co., Ltd.) at 37 ° C. for 48 hours. did. At each serially diluted concentration, the presence or absence of colonies was visually confirmed, and the number of colonies with the highest dilution ratio among those that could be confirmed was counted, and the number of viable Bifidobacteria was determined from the result. The results are shown in Table 2.
表2に示したとおり、カボチャ破砕物は、1.5*109(CFU/g)の結果を示し、通常ビフィズス菌の培養に使用されるMRS培地(4.7*108(CFU/g))やMRS培地にシステインを添加した培地(7.1*108(CFU/g))に比べ、優れた生菌残存効果を有することが判った。一方、リンゴ破砕物(2.3*107(CFU/g))には生菌残存効果を確認できなかった。 As shown in Table 2, the pumpkin crushed material showed a result of 1.5 * 10 9 (CFU / g), and is usually an MRS medium (4.7 * 10 8 (CFU / g) used for culture of bifidobacteria. )) And MRS medium supplemented with cysteine (7.1 * 10 8 (CFU / g)), it was found to have an excellent survival effect on viable bacteria. On the other hand, the viable cell residual effect could not be confirmed in the crushed apple (2.3 * 10 7 (CFU / g)).
経口摂取による腸内ビフィズス菌の増殖活性評価
日本チャールス・リバー(株)より、5週齢の雄性マウス C57BL/6NCrlCrj(SPF)を購入し、入荷から実験開始まで7日間馴化・検疫を行い、7日目に群分けした(1群につき10匹のマウスを割り当て、A〜D群の4群に分けた)。どの群のマウスにも、高脂肪食飼料D12492(60 kcal%、Research Diet Inc.)を自由摂取させた。また、これに加えて、B群のマウスにはビフィドバクテリウム・ブレーベ菌末をC群のマウスにはビフィドバクテリウム・ブレーベ菌末及びカボチャ粉末を、それぞれ与えた。つまり、以下のように各群に餌を与えた。
A群:高脂肪食飼料
B群:高脂肪食飼料+ビフィドバクテリウム・ブレーベ菌末
C群:高脂肪食飼料+ビフィドバクテリウム・ブレーベ菌末+カボチャ粉末
(カボチャ粉末:日本粉末薬品(株)社製、カボチャ末)
なお、ビフィドバクテリウム・ブレーベ菌末投与量は10mg(5×108CFU相当)、野菜粉末の投与量は100mg/30g体重・日とし、これらは経口ゾンデを装着した注射筒(ディスポーザブルシリンジ,テルモ(株))に充填して1回/日の頻度でマウスへ経口投与した。
投与期間は84日間とし、84日目糞便の採取を行い、糞便中の全細菌量に対するビフィズス菌量の割合を、株式会社 テクノスルガ・ラボ(リアルタイムPCR法)に委託を行い測定した。
高脂肪食誘導肥満マウスを用いた、ビフィズス菌及びカボチャの摂取によるビフィズス菌増殖促進効果の測定結果を表3に示す。具体的には、高脂肪食飼料、ビフィズス菌(ビフィドバクテリウム・ブレーベ菌末)、カボチャ粉末を組み合わせて摂取させたマウスの糞便中の全細菌量に対するビフィズス菌量の割合(n=10の平均値)を示す。
Evaluation of intestinal bifidobacterial growth activity by oral ingestion Purchased 5-week-old male mouse C57BL / 6NCrlCrj (SPF) from Japan Charles River Co., Ltd. Groups were grouped on day (10 mice were assigned per group and divided into 4 groups, groups A to D). All groups of mice received the high fat diet D12492 (60 kcal%, Research Diet Inc.) ad libitum. In addition, Bifidobacterium breve powder was given to group B mice, and Bifidobacterium breve powder and pumpkin powder were given to group C mice, respectively. That is, each group was fed as follows.
Group A: High-fat diet feed Group B: High-fat diet feed + Bifidobacterium breve fungus powder Group C: High-fat diet feed + Bifidobacterium breve powder + pumpkin powder
(Pumpkin powder: made by Nippon Powder Chemical Co., Ltd., pumpkin powder)
The dose of Bifidobacterium breve powder is 10 mg (equivalent to 5 × 10 8 CFU), the dose of vegetable powder is 100 mg / 30 g body weight / day, and these are syringes equipped with an oral sonde (disposable syringe, Terumo Co., Ltd.) and orally administered to mice at a frequency of once / day.
The administration period was 84 days, stool was collected on the 84th day, and the ratio of the amount of bifidobacteria to the total amount of bacteria in the stool was consigned to Techno Suruga Lab Co., Ltd. (real-time PCR method) and measured.
Table 3 shows the measurement results of the bifidobacteria growth-promoting effect by ingestion of bifidobacteria and pumpkins using high fat diet-induced obese mice. Specifically, the ratio of the amount of bifidobacteria to the total amount of bacteria in the feces of mice ingested in combination with a high fat diet, bifidobacteria (bifidobacterium breve powder) and pumpkin powder (n = 10 Average value).
対照群であるA群(高脂肪食群:0.1)に比べて、B群及びC群共にマウスの糞便中の全細菌量に対するビフィズス菌の割合が顕著に高くなり、かつ、B群(ビフィズス菌末単独投与群:5.0)に比べ、C群(ビフィズス菌・カボチャ併用投与群:6.3)における「マウスの糞便中の全細菌量に対するビフィズス菌の割合」高くなっていることを確認した。 Compared with the control group A (high fat diet group: 0.1), the ratio of bifidobacteria to the total amount of bacteria in the stool of mice was significantly higher in both groups B and C, and group B ( Compared to the bifidobacteria powder alone administration group: 5.0), the “ratio of bifidobacteria to the total amount of bacteria in the stool of mice” in group C (bifidobacteria / pumpkin combination administration group: 6.3) is higher. It was confirmed.
処方例:飲料
カボチャ破砕物30質量部、ブロッコリピューレ20質量部、フレーバーからなる被醗酵物を、ビフィドバクテリウム・ロンガムを用いて、37℃で24時間、嫌気性下で醗酵処理させて得られたビフィズス菌の醗酵物をそのまま飲料組成物とする。
Formulation example: Beverage Fermented product consisting of 30 parts by weight of crushed pumpkin, 20 parts by weight of broccoli puree and flavor, fermented under anaerobic conditions at 37 ° C for 24 hours using Bifidobacterium longum. The fermented bifidobacteria obtained by processing is directly used as a beverage composition.
Claims (6)
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁 A method for growing bifidobacteria using a composition containing a processed pumpkin of the following (A) or (B).
(A) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁 A bifidobacteria growth promoter comprising a composition comprising the following processed pumpkin (A) or (B).
(A) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition
(C)組成物全量に対して30質量%以上のカボチャ破砕物
(D)組成物全量に対して16質量%以上のカボチャ搾汁 The bifidobacteria fermented product of the composition containing the pumpkin processed material of the following (C) or (D).
(C) Pumpkin crushed product of 30% by mass or more with respect to the total amount of the composition (D) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁 A method for growing intestinal bifidobacteria using an oral composition containing the processed pumpkin (B) or bifidobacteria of (A) or (B) below.
(A) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition
(A)組成物全量に対して30質量%以上のカボチャ破砕物
(B)組成物全量に対して16質量%以上のカボチャ搾汁 An intestinal bifidobacteria growth promoter comprising an oral composition containing the following processed pumpkin (A) or (B) and bifidobacteria.
(A) Pumpkin crushed material of 30% by mass or more with respect to the total amount of the composition (B) Pumpkin juice of 16% by mass or more with respect to the total amount of the composition
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014158382A JP2015198638A (en) | 2014-03-31 | 2014-08-04 | Bifidobacteria fermentation method and proliferation method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014072724 | 2014-03-31 | ||
JP2014072724 | 2014-03-31 | ||
JP2014158382A JP2015198638A (en) | 2014-03-31 | 2014-08-04 | Bifidobacteria fermentation method and proliferation method |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2015198638A true JP2015198638A (en) | 2015-11-12 |
Family
ID=54550584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014158382A Pending JP2015198638A (en) | 2014-03-31 | 2014-08-04 | Bifidobacteria fermentation method and proliferation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2015198638A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017169966A1 (en) * | 2016-03-28 | 2017-10-05 | 日清食品ホールディングス株式会社 | Bifidobacterium having serotonin-secretion-promoting ability |
WO2021206106A1 (en) * | 2020-04-08 | 2021-10-14 | 雪印メグミルク株式会社 | Composition for improving intestinal bacterial flora |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02242667A (en) * | 1989-03-15 | 1990-09-27 | Tokyo Tanabe Co Ltd | Proliferation accelerator for bacterium of genus bifidobacterium |
JP3051021U (en) * | 1998-01-29 | 1998-08-11 | 株式会社クレッセンドコーポレーション | Health promotion agent by combination of Bifidobacterium and certain oligosaccharides |
JP3052131U (en) * | 1998-03-10 | 1998-09-14 | 株式会社クレッセンドコーポレーション | Stick packaging bag with combination of bifidobacteria and oligosaccharide |
JP2003012526A (en) * | 2001-06-27 | 2003-01-15 | Sunstar Inc | Pharmaceutical preparation including useful live bacterium |
JP2003250528A (en) * | 2002-03-06 | 2003-09-09 | Yakult Honsha Co Ltd | Method for producing a survival improver, a growth promoter, or a fermentation product containing the bacterium belonging to the genus Bifidobacterium |
-
2014
- 2014-08-04 JP JP2014158382A patent/JP2015198638A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02242667A (en) * | 1989-03-15 | 1990-09-27 | Tokyo Tanabe Co Ltd | Proliferation accelerator for bacterium of genus bifidobacterium |
JP3051021U (en) * | 1998-01-29 | 1998-08-11 | 株式会社クレッセンドコーポレーション | Health promotion agent by combination of Bifidobacterium and certain oligosaccharides |
JP3052131U (en) * | 1998-03-10 | 1998-09-14 | 株式会社クレッセンドコーポレーション | Stick packaging bag with combination of bifidobacteria and oligosaccharide |
JP2003012526A (en) * | 2001-06-27 | 2003-01-15 | Sunstar Inc | Pharmaceutical preparation including useful live bacterium |
JP2003250528A (en) * | 2002-03-06 | 2003-09-09 | Yakult Honsha Co Ltd | Method for producing a survival improver, a growth promoter, or a fermentation product containing the bacterium belonging to the genus Bifidobacterium |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017169966A1 (en) * | 2016-03-28 | 2017-10-05 | 日清食品ホールディングス株式会社 | Bifidobacterium having serotonin-secretion-promoting ability |
JP2017175949A (en) * | 2016-03-28 | 2017-10-05 | 日清食品ホールディングス株式会社 | Bifidobacteria with serotonin excretion enhancing capacity |
WO2021206106A1 (en) * | 2020-04-08 | 2021-10-14 | 雪印メグミルク株式会社 | Composition for improving intestinal bacterial flora |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105054040B (en) | A kind of composition of probiotics fermention ginseng and its preparation method and application | |
JP6796070B2 (en) | Foods and drinks containing indigestible components and hydrogen gas producing agents in the large intestine | |
WO2019112054A1 (en) | Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria | |
CN105249100B (en) | The production method of fermented fruits and vegetables juice and fermented glutinous rice beverage with compound functions | |
CN111935995A (en) | Nutritional composition, and food and drink composition and formulated milk powder using the same | |
JP2019528763A (en) | Novel Lactobacillus sakei and composition containing the same | |
CN107530387B (en) | Oral composition containing Bifidobacterium and cruciferous vegetable | |
WO2019112053A1 (en) | Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria | |
JP6301024B2 (en) | Felicaribacterium spp. | |
KR20040027180A (en) | Lactic Acid Bacteria-Fermenting Dairy Products Used for Preventing and Treating Obesity or Diabetes Mellitus and Manufacturing Method thereof | |
US11478525B2 (en) | Method for promoting growth of Akkermansia muciniphila using musa ferments | |
JP2007082403A (en) | Food and drink containing complex composition comprising yucca extract, quillaia extract and lactobacillus, and method for producing the same | |
JP4762987B2 (en) | Antihypertensive agent obtained by lactic acid bacteria culture | |
JP6061842B2 (en) | QOL improvement or persistence agent | |
JP6998193B2 (en) | A novel Bifidobacterium bacterium and a composition containing the bacterium. | |
CN111035661A (en) | Application of lactobacillus plantarum | |
JP2015198638A (en) | Bifidobacteria fermentation method and proliferation method | |
JP5967527B2 (en) | Appetite increase and weight gain inhibitor | |
WO2023150628A2 (en) | Probiotic strain selected by targeted in vivo enrichment to aid with healthy lactose digestion | |
JP5413819B2 (en) | Liver function improving agent and its production tool, and use thereof | |
JP7368484B2 (en) | Composition, food and beverage compositions containing the composition, and formula milk | |
JP2876541B2 (en) | Bifidobacterium growth promoter | |
KR20200098224A (en) | Prebiotics comprising polysaccharide from residues of immature citrus extract or immature citrus peel and composition comprising the same as an active ingredient for promoting probiotics proliferation | |
KR102515677B1 (en) | Composition containing lactic acid bacteria coated with lithotamnion to improve intestinal health and ability to suppress harmful bacteria | |
Paliy et al. | Influence of various prebiotic components on the main growth indicators of probiotic bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170802 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180724 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20180730 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180912 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190328 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190806 |